• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Diabetes

Lilly
Pharma

Lilly lifts guidance on back of another lucrative GLP-1 quarter

Foundayo is capturing roughly 4 in 10 new U.S. oral obesity drug prescriptions, Lilly's Ilya Yuffa told analysts Thursday.
Fraiser Kansteiner Oct 29, 2026 3:31pm
Lilly

Lilly surges up diabetes reputation rankings to close in on Novo

Oct 28, 2026 3:18am
locking horns

Novo, Lilly unleash dueling GLP-1 datasets at EASD in Milan

Sep 29, 2026 11:20am
Novo Mike Doustdar 2

Novo struggles to appease restless investors with new strategy

Sep 21, 2026 10:50am
Mike Doustdar

Novo CEO talks embracing change and staying bullish amid rebrand

Sep 17, 2026 8:45am
Novo Nordisk insulin insulin vial Novo

UK cost watchdog endorses Lilly's weekly insulin injectable

Aug 20, 2026 9:12am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings